Xebra Brands Announces Update on Share Consolidation
Xebra Brands (CSE:XBRA) announced the implementation of its previously disclosed 1-for-10 share consolidation, effective September 19, 2025. The consolidation will reduce outstanding shares to approximately 8,065,442. However, trading remains suspended due to a cease trade order (CTO) issued by the British Columbia Securities Commission on September 3, 2025.
The CTO resulted from Xebra's failure to file required financial documents, including annual statements for the year ended February 28, 2025, and interim filings for Q1 2025. The company will maintain its current name and trading symbol, with new CUSIP (98402E305) and ISIN (CA98402E3059) numbers assigned. Trading will remain halted until the company files the required documents and the CTO is lifted.
Xebra Brands (CSE:XBRA) ha annunciato l'attuazione della consolidazione azionaria di 1-for-10 già comunicata, efficace dal 19 settembre 2025. Le azioni in circolazione dovrebbero ridursi a circa 8.065.442. Tuttavia il trading resta sospeso a causa di un ordine di cessazione del commercio (CTO) emesso dalla British Columbia Securities Commission il 3 settembre 2025.
Il CTO è derivato dal mancato deposito dei documenti finanziari richiesti, includendo i bilanci annuali per l'anno chiuso al 28 febbraio 2025 e i rendiconti interimi per il primo trimestre 2025. La società manterrà il proprio nome e simbolo di negoziazione, con nuovi numeri CUSIP (98402E305) e ISIN (CA98402E3059) assegnati. Il trading rimarrà interrotto finché la società non presenterà i documenti richiesti e il CTO non sarà revocato.
Xebra Brands (CSE:XBRA) ha anunciado la implementación de la consolidación de acciones de 1 por 10 previamente comunicada, que entrará en vigor el 19 de septiembre de 2025. Las acciones en circulación se reducirán a aproximadamente 8.065.442. Sin embargo, la negociación sigue suspendida debido a una orden de cese de operaciones (CTO) emitida por la British Columbia Securities Commission el 3 de septiembre de 2025.
El CTO se debió a la falta de presentación de los documentos financieros requeridos, incluyendo los estados anuales del año terminado el 28 de febrero de 2025 y los informes interinos del primer trimestre de 2025. La compañía mantendrá su nombre y símbolo de cotización actuales, con nuevos números CUSIP (98402E305) e ISIN (CA98402E3059) asignados. La negociación permanecerá detenida hasta que la empresa presente los documentos requeridos y se levante el CTO.
Xebra Brands (CSE:XBRA)은 1대 10 주식 통합을 이미 공표한 대로 2025년 9월 19일부로 시행한다고 발표했습니다. 유통 주식은 대략 8,065,442주로 감소합니다. 그러나 2025년 9월 3일 브리티시컬럼비아 증권거래위원회가 발령한 거래정지 명령(CTO)로 거래는 여전히 중단된 상태입니다.
CTO는 2025년 2월 28일 종료 연도 및 2025년 1분기 중간 재무제표를 포함해 필요한 재무 문서를 제출하지 않은 데에서 비롯되었습니다. 회사는 현재의 이름과 거래 기호를 유지하지만 새로운 CUSIP(98402E305) 및 ISIN(CA98402E3059) 번호가 부여됩니다. 필요한 문서를 제출하고 CTO가 해제될 때까지 거래가 중단된 상태로 남습니다.
Xebra Brands (CSE:XBRA) a annoncé la mise en œuvre de la consolidation d’actions de 1 pour 10 déjà communiquée, effective le 19 septembre 2025. Le nombre d’actions en circulation sera d’environ 8 065 442. Toutefois, les échanges restent suspension en raison d’un ordre de cessation de négociation (CTO) délivré par la British Columbia Securities Commission le 3 septembre 2025.
Le CTO résulte du fait que Xebra n’a pas déposé les documents financiers requis, notamment les états annuels pour l’exercice clos le 28 février 2025 et les comptes intermédiaires du premier trimestre 2025. La société conservera son nom et son symbole de cotation actuels, avec de nouveaux numéros CUSIP (98402E305) et ISIN (CA98402E3059) attribués. La négociation restera suspendue tant que les documents requis ne seront pas déposés et que le CTO ne sera levé.
Xebra Brands (CSE:XBRA) hat die zuvor angekündigte 1-für-10-Aktienzusammenlegung umgesetzt, die am 19. September 2025 in Kraft tritt. Die umlaufenden Aktien werden auf rund 8.065.442 reduziert. Der Handel bleibt jedoch aufgrund einer von der British Columbia Securities Commission am 3. September 2025 erlassenen Handelsunterbrechungsanordnung (CTO) ausgesetzt.
Der CTO entstand durch das Versäumnis des Unternehmens, die erforderlichen Finanzunterlagen einzureichen, einschließlich der Jahresabschlüsse für das am 28. Februar 2025 endende Jahr und der Zwischenberichte für das erste Quartal 2025. Das Unternehmen behält seinen aktuellen Namen und Handelssymbol bei, erhält jedoch neue CUSIP-Nummer (98402E305) und ISIN (CA98402E3059). Der Handel bleibt ausgesetzt, bis die erforderlichen Dokumente eingereicht und der CTO aufgehoben wird.
Xebra Brands (CSE:XBRA) أعلنت عن تنفيذ تجميع الأسهم 1 مقابل 10 الذي تم الكشف عنه سابقاً، وسيدخل حيز التنفيذ في 19 سبتمبر 2025. ستنخفض الأسهم القائمة إلى نحو 8,065,442. مع ذلك، لا يزال التداول معلقاً بسبب أمر وقف التداول (CTO) صدر عن هيئة الأوراق المالية في كولومبيا البريطانية في 3 سبتمبر 2025.
نتيجة CTO هي فشل الشركة في تقديم الوثائق المالية المطلوبة، بما في ذلك القوائم السنوية للسنة المنتهية في 28 فبراير 2025 والتقارير المرحلية للربع الأول من 2025. ستحتفظ الشركة باسمها ورمز التداول الحاليين، مع منح أعداد CUSIP (98402E305) و ISIN (CA98402E3059) جديدة. سيظل التداول معلقاً حتى تقدم الشركة الوثائق المطلوبة وتُرفع CTO.
Xebra Brands (CSE:XBRA) 宣布实施先前披露的1比10股本合并，自2025年9月19日起生效。合并后在外的流通股数将约为8,065,442股。然而，由于不列颠哥伦比亚省证券委员会于2025年9月3日发出的交易停止令（CTO），交易仍处于暂停状态。
CTO 是因为公司未能提交所需的财务文件，包括截至2025年2月28日止年度报表以及2025年第一季度的中期报表。公司将维持其现有名称和交易代码，并分配新的CUSIP(98402E305)和ISIN(CA98402E3059)号码。只有公司提交所需文件并解除CTO，交易才会恢复。
- None.
- Company under cease trade order (CTO) for failing to file required financial documents
- Trading of shares suspended until regulatory compliance is achieved
- Significant share dilution with 10:1 consolidation ratio
VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025) consolidation of its issued and outstanding share capital on the basis of one (1) post-consolidation common share for each ten (10) pre-consolidation common shares (the "Consolidation") will become effective on September 19, 2025.
Further to the Company's press release dated August 22, 2025, the British Columbia Securities Commission (the "BCSC") issued a failure to file cease trade order ("CTO") on September 3, 2025 for the Company's failure to file its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended February 28, 2025 and its unaudited interim financial statements, related management's discussion and analysis and officer certifications for the three months ended May 31, 2025 (the "Interim Filings", and together with the Annual Filings, the "Required Documents"). Notwithstanding that the Consolidation will become effective on September 19, 2025, the Company's common shares will remain cease trade until such time that it files the Required Documents and the CTO is revoked by the BCSC.
Xebra will not be changing its name or trading symbol in connection with the Consolidation. As a result of the Consolidation, the outstanding common shares of Xebra will be reduced to approximately 8,065,442. No fractional common shares will be issued upon the Consolidation. In the event a holder of common shares would otherwise be entitled to receive a fractional common share in connection with the Consolidation, the number of common shares to be received by such shareholder will be rounded down to the next whole number if that fractional common share is less than one half (1/2) of a common share, and will be rounded up to the next whole number of common shares if that fractional common share is equal to or greater than one half (1/2) of a common share. The new CUSIP number will be 98402E305 and the new ISIN number will be CA98402E3059.
A letter of transmittal will be sent to registered shareholders advising that the Consolidation has taken effect. The letter of transmittal will contain instructions on how registered shareholders can exchange their share certificates evidencing their pre‐Consolidation common shares for new share certificates representing the number of post-Consolidation common shares to which they are entitled. No action is required by non‐registered shareholders (shareholders who hold their shares through an intermediary) to affect the Consolidation. The exercise or conversion price of, and the number of common shares issuable under, any convertible securities of Xebra will be proportionately adjusted upon the completion of the Consolidation.
The Consolidation is subject to the receipt of all required regulatory approval, including acceptance of the Canadian Securities Exchange (the "CSE").
New CUSIP: 98402E305
New ISIN: CA98402E3059
Effective Date of Consolidation: September 19, 2025.
Record Date: September 22, 2025.
On behalf of the Board
Rodrigo Gallardo
Interim CEO
For more information, contact:
+52 (55) 6387-2293
ir@xebrabrands.com
www.xebrabrands.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
Certain information contained in this press release constitutes forward-looking information or forward-looking statements under applicable securities laws. Any statements that are not statements of historical fact may be deemed to be forward-looking statements, these include, without limitation, statements regarding Xebra Brands Ltd.'s expectations in respect statements, projections and estimates with respect to the Consolidation, the timing of the Consolidation and the Consolidation ratio, statements with respect to the filing of the Required Filings, the expectation that the Annual Financial Filings will be filed by the Filing Deadline, the expected number of issued and outstanding common shares on a post-Consolidation basis, the mailing of letters of transmittal, Xebra's ability to provide economic, environmental, social, or any benefits of any type, in the communities it operates in or may operate it in the future; its ability to be a first mover in a country, or to obtain or retain government licenses, permits or authorizations in general, or specifically in Mexico, Canada, or elsewhere, including cannabis authorizations from the Mexican Health Regulatory Agency (COFEPRIS) and the timing of such permits or authorizations; its ability to successfully apply for and obtain trademarks and other intellectual property in any jurisdiction; its ability to be cost competitive; its ability to commercialize, cultivate, grow, or process hemp or cannabis in Mexico, Canada, or elsewhere and related plans and timing; its ability to manufacture, commercialize or sell cannabis-infused beverages, wellness products, or other products in Mexico, Canada, or elsewhere, and its related plans and claims, including market interest and availability; its ability to create wellness products that have a therapeutic effect or benefit; plans for future growth and the direction of the business; financial projections including expected revenues, gross profits, and EBITDA (which is a non-GAAP financial measure); plans to increase product volumes, the capacity of existing facilities, supplies from third party growers and contractors; expected growth of the cannabis industry generally; management's expectations, beliefs and assumptions in general, including manufacturing costs, production activity and market potential in Mexico or any jurisdiction; events or developments that XEBRA expects to take place in the future; general economic conditions; and other risk factors described in the prospectus of the Company dated September 30, 2021. All statements, other than statements of historical facts, are forward-looking information and statements. The words "aim", "believe", "expect", "anticipate", "contemplate", "target", "intends", "continue", "plans", "budget", "estimate", "may", "will", and similar expressions identify forward-looking information and statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by XEBRA as of the dates of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to, the inability to complete the audit on the Annual Filings due to a requirement for additional funds, the inability of XEBRA to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete a potential acquisition for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; and the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approval for license applications. In addition, there is no assurance Xebra will: be a low-cost producer or exporter; obtain a dominant market position in any jurisdiction; have products that will be unique. The foregoing list is not exhaustive and XEBRA undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect XEBRA's actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, XEBRA. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.
SOURCE: Xebra Brands Ltd
View the original press release on ACCESS Newswire
FAQ
What is the share consolidation ratio for Xebra Brands (CSE:XBRA)?
When will Xebra Brands' share consolidation become effective?
Why was a cease trade order issued for Xebra Brands?
How many shares will Xebra Brands have outstanding after the consolidation?
What are the new CUSIP and ISIN numbers for Xebra Brands shares?
